Patents by Inventor Johanna RÜHMANN

Johanna RÜHMANN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PD-L1 AND TA-MUC1 ANTIBODIES
    Publication number: 20200148785
    Abstract: The present invention relates to an antibody which effects enhanced T cell activation in comparison to a reference antibody being glycosylated including more than 80% core-fucosylation and wherein T cell activation is effected by an antibody characterized by enhanced binding to Fc#RIIIa. Said antibody is glycosylated, but essentially lacks core-fucosylation.
    Type: Application
    Filed: March 28, 2018
    Publication date: May 14, 2020
    Inventors: Patrik Kehler, Steffen Goletz, Antje Danielczyk, Johanna Ruehmann, Christoph Goletz
  • ANTI-CANCER TREATMENTS WITH AN ANTI-MUC1 ANTIBODY AND AN ERBB INHIBITOR
    Publication number: 20190343953
    Abstract: The present invention pertains to the field of cancer therapy using anti-cancer antibodies. The medical use of anti-MUC1 antibodies in combination with inhibitors of the ErbB receptor family is provided which show synergistic anti-cancer efficacy.
    Type: Application
    Filed: January 24, 2018
    Publication date: November 14, 2019
    Inventors: Steffen GOLETZ, Johanna RÜHMANN, Beate HABEL, Felix HART